What digitalization in biology R&D means for biotech companies and life scientists - Nature Biotechnology

South Africa News News

What digitalization in biology R&D means for biotech companies and life scientists - Nature Biotechnology
South Africa South Africa Latest News,South Africa South Africa Headlines

What digitalization in biology R&D means for biotech companies and life scientists

  • πŸ“° NatureBiotech
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • πŸ“Š Quality Score:
  • News: 8%
  • Publisher: 63%

Biological research and development is a hugely costly business for small and emerging biotechnology companies. The median R&D cost per drug, from data collected between 2009 to 2018, is estimated at $985 million.

Biological research and development is a hugely costly business for small and emerging biotechnology companies. The median R&D cost per drug, from data collected between 2009 to 2018, is estimated at $985 million
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NatureBiotech /  πŸ† 231. in ZA
 

Very forward-looking piece πŸ™ describing the digital life science lab 🀩 β€œIt is not possible to simply introduce leading datascience techniques without undertaking the right digitalization steps in laboratory-level experiment design, execution and analysis.” πŸ‘

This is relevant to and vice versa.

synthace The digitalization of R&D can potentially transform the life sciences, but it cannot succeed without experts collaborating to develop a vision of what a better working environment can look like. Lead author Markus Gershater goes behindthepaper

synthace Nature Biotech is publishing company white papers now?

South Africa South Africa Latest News, South Africa South Africa Headlines



Render Time: 2025-01-16 13:42:39